olmesartan has been researched along with Infarct in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baylis, C; Moningka, NC; Sasser, JM; Tsarova, T | 1 |
1 other study(ies) available for olmesartan and Infarct
| Article | Year |
|---|---|
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzopyrans; Blotting, Western; Chromatography, High Pressure Liquid; Disease Models, Animal; Ethanolamines; Imidazoles; Infarction; Kidney Cortex; Kidney Failure, Chronic; Male; Nebivolol; Rats; Rats, Sprague-Dawley; Tetrazoles | 2012 |